Clinical Case Studies in Heart Failure Management

Overview

Journal Br J Clin Pharmacol

Specialty Pharmacology

Date 1999 Apr 24

PMID 10215746

Authors

R J MacFadyen

P Shiels

A D Struthers

Affiliations

Soon will be listed here.

References

Uretsky B, Young J, Shahidi F, Yellen L, Harrison M, Jolly M . Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group. J Am Coll Cardiol. 1993; 22(4):955-62. DOI: 10.1016/0735-1097(93)90403-n. View

Hall S, Cigarroa C, Marcoux L, Risser R, Grayburn P, Eichhorn E . Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade. J Am Coll Cardiol. 1995; 25(5):1154-61. DOI: 10.1016/0735-1097(94)00543-y. View

Doughty R, Sharpe N . Beta-adrenergic blocking agents in the treatment of congestive heart failure: mechanisms and clinical results. Annu Rev Med. 1997; 48:103-14. DOI: 10.1146/annurev.med.48.1.103. View

. Are implantable cardioverter-defibrillators or drugs more effective in prolonging life? The Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial Executive Committee. Am J Cardiol. 1997; 79(5):661-3. View

Cohn J . Physiological rationale for co-treatment with diuretics in heart failure. Br Heart J. 1994; 72(2 Suppl):S63-7. PMC: 1025579. DOI: 10.1136/hrt.72.2_suppl.s63. View

Lacourciere Y, Brunner H, Irwin R, Karlberg B, Ramsay L, Snavely D . Effects of modulators of the renin-angiotensin-aldosterone system on cough. Losartan Cough Study Group. J Hypertens. 1994; 12(12):1387-93. View

Jenkinson C, Jenkinson D, Shepperd S, Layte R, Petersen S . Evaluation of treatment for congestive heart failure in patients aged 60 years and older using generic measures of health status (SF-36 and COOP charts). Age Ageing. 1997; 26(1):7-13. DOI: 10.1093/ageing/26.1.7. View

Packer M, Lee W, Medina N, Yushak M, Kessler P . Functional renal insufficiency during long-term therapy with captopril and enalapril in severe chronic heart failure. Ann Intern Med. 1987; 106(3):346-54. DOI: 10.7326/0003-4819-106-3-346. View

Azizi M, Chatellier G, Guyene T, Menard J . Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives. Circulation. 1995; 92(4):825-34. DOI: 10.1161/01.cir.92.4.825. View

10.

Curfman G . Inotropic therapy for heart failure--an unfulfilled promise. N Engl J Med. 1991; 325(21):1509-10. DOI: 10.1056/NEJM199111213252111. View

11.

Gottlieb S, Robinson S, Weir M, Fisher M, Krichten C . Determinants of the renal response to ACE inhibition in patients with congestive heart failure. Am Heart J. 1992; 124(1):131-6. DOI: 10.1016/0002-8703(92)90930-t. View

12.

West J, Miller N, Parker K, Senneca D, Ghandour G, Clark M . A comprehensive management system for heart failure improves clinical outcomes and reduces medical resource utilization. Am J Cardiol. 1997; 79(1):58-63. DOI: 10.1016/s0002-9149(96)00676-5. View

13.

Packer M . Do angiotensin-converting enzyme inhibitors prolong life in patients with heart failure treated in clinical practice?. J Am Coll Cardiol. 1996; 28(5):1323-7. DOI: 10.1016/S0735-1097(96)00301-4. View

14.

Pfeffer M, Braunwald E, Moye L, Basta L, Brown Jr E, Cuddy T . Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med. 1992; 327(10):669-77. DOI: 10.1056/NEJM199209033271001. View

15.

Poole-Wilson P . Heart failure. Unfinished business--a possible role for vasodilators. Int J Cardiol. 1993; 40(1):1-6. DOI: 10.1016/0167-5273(93)90224-5. View

16.

Choy A, Darbar D, Lang C, Pringle T, McNeill G, Kennedy N . Detection of left ventricular dysfunction after acute myocardial infarction: comparison of clinical, echocardiographic, and neurohormonal methods. Br Heart J. 1994; 72(1):16-22. PMC: 1025420. DOI: 10.1136/hrt.72.1.16. View

17.

MacFadyen R, Jones C, Doig J, Birnbock H, Reid J . Responses to an orally active renin inhibitor, remikiren (Ro 42-5892), after controlled salt depletion in humans. J Cardiovasc Pharmacol. 1995; 25(3):347-53. DOI: 10.1097/00005344-199503000-00001. View

18.

Cohn J, Johnson G, Ziesche S, Cobb F, Francis G, Tristani F . A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 1991; 325(5):303-10. DOI: 10.1056/NEJM199108013250502. View

19.

Vantrimpont P, Rouleau J, Wun C, Ciampi A, Klein M, Sussex B . Additive beneficial effects of beta-blockers to angiotensin-converting enzyme inhibitors in the Survival and Ventricular Enlargement (SAVE) Study. SAVE Investigators. J Am Coll Cardiol. 1997; 29(2):229-36. DOI: 10.1016/s0735-1097(96)00489-5. View

20.

Raftery E . Haemodynamic effects of diuretics in heart failure. Br Heart J. 1994; 72(2 Suppl):S44-7. PMC: 1025574. DOI: 10.1136/hrt.72.2_suppl.s44. View